AGAPE ATP CORPORATION Cost of Revenue
AGAPE ATP CORPORATION (ATPC) reported Cost of Revenue of $1.92 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2026-08-14
- AGAPE ATP CORPORATION cost of revenue for the quarter ending 2026-06-30 was $1.92K, a 98.64% decline year-over-year.
- AGAPE ATP CORPORATION cost of revenue for the quarter ending 2026-03-31 was $114.25K, a 13.94% decline year-over-year.
- AGAPE ATP CORPORATION cost of revenue for the quarter ending 2025-12-31 was $165.19K, a 9.13% decline year-over-year.
- AGAPE ATP CORPORATION cost of revenue for the quarter ending 2025-09-30 was $131.49K, a 10.61% decline year-over-year.
- AGAPE ATP CORPORATION cost of revenue for fiscal 2025 was $685.99K, a 21.72% increase from fiscal 2024.
- AGAPE ATP CORPORATION cost of revenue for fiscal 2024 was $563.60K, a 13.97% increase from fiscal 2023.
- AGAPE ATP CORPORATION cost of revenue for fiscal 2023 was $494.52K, a 25.75% decline from fiscal 2022.
- AGAPE ATP CORPORATION cost of revenue for fiscal 2022 was $666.04K.
| Period end | Cost of Revenue 3 month | Cost of Revenue 3 month as first filed | Cost of Revenue 6 month | Cost of Revenue 6 month as first filed | Cost of Revenue 9 month | Cost of Revenue 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1.92K 10-Q · filed 2026-08-14 | $7.22K 10-Q · filed 2026-08-14 | $281.36K derived: sum of 3 quarters · filed 2026-08-14 | $412.85K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2026-03-31 | $114.25K 10-Q · filed 2026-05-15 | $279.44K derived: sum of 2 quarters · filed 2026-05-15 | $410.93K derived: sum of 3 quarters · filed 2026-05-15 | $552.59K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-12-31 | $165.19K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-13 | $296.68K derived: sum of 2 quarters · filed 2026-04-13 | $438.34K derived: sum of 3 quarters · filed 2026-08-14 | $685.99K 10-K · filed 2026-04-13 | ||
| 2025-09-30 | $131.49K 10-Q · filed 2025-11-13 | $273.15K derived: sum of 2 quarters · filed 2026-08-14 | $520.80K 10-Q · filed 2025-11-13 | $587.70K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-06-30 | $141.66K 10-Q · filed 2026-08-14 | $256.56K 10-Q · filed 2025-08-13 | $156.67K 10-Q · filed 2026-08-14 | $389.31K 10-Q · filed 2025-08-13 | $456.21K derived: sum of 3 quarters · filed 2026-08-14 | $603.31K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $132.75K 10-Q · filed 2026-05-15 | $314.55K derived: sum of 2 quarters · filed 2026-05-15 | $461.65K derived: sum of 3 quarters · filed 2026-05-15 | $581.13K derived: sum of 4 quarters · filed 2026-05-15 | ||
| 2024-12-31 | $181.79K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-13 | $328.90K derived: sum of 2 quarters · filed 2026-04-13 | $448.38K derived: sum of 3 quarters · filed 2026-04-13 | $563.60K 10-K · filed 2026-04-13 | ||
| 2024-09-30 | $147.10K 10-Q · filed 2025-11-13 | $266.58K derived: sum of 2 quarters · filed 2025-11-13 | $381.81K 10-Q · filed 2025-11-13 | $519.45K derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | $119.48K 10-Q · filed 2025-08-13 | $234.70K 10-Q · filed 2025-08-13 | $372.34K derived: sum of 3 quarters · filed 2025-08-13 | $492.93K derived: sum of 4 quarters · filed 2025-08-13 | ||
| 2024-03-31 | $115.22K 10-Q · filed 2025-05-15 | $252.86K derived: sum of 2 quarters · filed 2025-05-15 | $373.45K derived: sum of 3 quarters · filed 2025-05-15 | $481.38K derived: sum of 4 quarters · filed 2025-05-15 | ||
| 2023-12-31 | $137.64K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $258.23K derived: sum of 2 quarters · filed 2025-03-31 | $366.16K derived: sum of 3 quarters · filed 2025-03-31 | $494.52K 10-K · filed 2025-03-31 | ||
| 2023-09-30 | $120.59K 10-Q · filed 2024-11-14 | $228.52K derived: sum of 2 quarters · filed 2024-11-14 | $356.88K 10-Q · filed 2024-11-14 | |||
| 2023-06-30 | $107.93K 10-Q · filed 2024-08-14 | $236.29K 10-Q · filed 2024-08-14 | ||||
| 2023-03-31 | $128.36K 10-Q · filed 2024-05-14 | |||||
| 2022-12-31 | $666.04K 10-K · filed 2024-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |